Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical firms, such as the makers of Xarelto, have a duty to ensure that their drugs are reasonably protected for use - and failure to do so might be grounds for compensation. Our lawyers are working tough to get those hurt by the drug the compensation they're entitled to.
Whilst bleeding is actually a widespread complication connected with anticoagulants, it has been alleged that Xarelto is far more dangerous than standard blood thinners simply because no antidote exists to reverse its blood-thinning effects. This indicates that, inside the event of an emergency, patients might be at threat for irreversible bleeding difficulties, like life-threatening internal and gastrointestinal hemorrhaging.
In the event you or a loved a single suffered a significant bleeding occasion right after taking Xarelto, you may have legal recourse. For far more info, make contact with us today to have your case reviewed, totally free of charge.
xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for past and future health-related bills, lost wages, pain and suffering and, in instances of death, funeral expenditures. In addition, they're seeking punitive damages, which are generally awarded to punish the defendant and deter other businesses from acting similarly.
Why Are Lawsuits Becoming Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective signifies of stopping
Xarelto users from bleeding inside the event of an emergency. Plaintiffs in the lawsuits allege severe and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user in the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.
Visit this page for a lot more info on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys within the Complex Litigation Group have filed lawsuits on behalf xareltoinformation.bitbucket.org
of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.